
|Videos|August 3, 2017
What is the Goal of Treat-to-Target in Patients with Rheumatoid Arthritis?
What is the importance and prevalence of treat-to-target?
Advertisement
Marcus H. Snow, MD, from University of Nebraska Medical Center, speaks about the importance of treat-to-target and its goal of disease remission in patients with rheumatoid arthritis. Dr. Snow believes that most physicians already practice an informal treat-to-target therapy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
4
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
5





















































































































































































































